Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01133197 · ClinicalTrials.gov registry record
The Impact of Thumb Carpometacarpal Osteoarthritis on General Health
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 188
- Enrollment target
NCT01133197: Completed study, sponsored by Washington University School of Medicine.
NCT01133197 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 188 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01133197 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
Study Summary
This study is designed to define the impact of thumb arthritis on patient's general health. As a secondary objective, data will be analyzed to determine the effects of medical and musculoskeletal comorbidities on the rating of upper extremity function by the patient.
Primary Outcome
Use of hand by Michigan Hand Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-06 |
What the finished NCT01133197 record still lists
NCT01133197 is an observational study that tracks outcomes without assigning an intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01133197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01133197 about?
NCT01133197 is a clinical study titled "The Impact of Thumb Carpometacarpal Osteoarthritis on General Health". This study is designed to define the impact of thumb arthritis on patient's general health. As a secondary objective, data will be analyzed to determine the effects of medical and musculoskeletal comorbidities on the rating of upper extremity function by the patient.
What is the current status of trial NCT01133197?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2009-07. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01133197?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia